Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

ObjectiveThe current study was designed with the aim of conducting a systematic review and meta-analysis to determine the circulating levels of visfatin in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals.MethodsUntil March 2024, we searched the Web of Scien...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nahid Aboutaleb, Alireza Moradi, Hamzeh Mirshekari Jahangiri, Mohammad Reza Aslani
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Medicine
Subjects:	visfatin meta-analysis COPD IL-6 BMI
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1432025/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The influence of age on the responses of serum visfatin and insulin resistance to a single session of endurance exercise
by: هیوا رحمانی, et al.
Published: (2013-04-01)

Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
by: Anna Maria Cybulska, et al.
Published: (2025-02-01)

The Role of Visfatin, Leptin, and IL-18 in Polycystic Ovarian Syndrome Patients
by: Sukayna H. Rashed, et al.
Published: (2024-12-01)

Evaluation of Salivary Chemerin and Visfatin in Relation to Periodontitis and Obesity
by: Farah Razak Abood, et al.
Published: (2025-04-01)

Association between serum interleukin- 6 concentrations, chronic obstructive pulmonary disease, and its relation to severity, acute exacerbation, and its effect on pulmonary function test
by: Samir Mohamed Mahmoud Fahyim, et al.
Published: (2025-04-01)

Pre- and Post-partum Levels of Serum Visfatin in Pregnant Women with Gestational Diabetes Mellitus: A Correlation
by: Samita Yasmin, et al.
Published: (2024-12-01)

Pre- and Post-partum Levels of Serum Visfatin in Pregnant Women with Gestational Diabetes Mellitus: A Correlation
by: Samita Yasmin, et al.
Published: (2024-12-01)

Elevated visfatin levels illuminate the inflammatory path in bronchopulmonary dysplasia
by: Berna Hoti, et al.
Published: (2024-12-01)

Correlation between serum inflammatory factors and psychosomatic syndrome in patients with chronic obstructive pulmonary disease: an observational study
by: Wenjing Zhang, et al.
Published: (2025-07-01)

Effects of peptides derived from active sites of visfatin on wound healing
by: Bo Sun Joo, et al.
Published: (2025-07-01)

Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
by: Wang Xiao-qi, et al.
Published: (2025-04-01)

Correlation between serum Visfatin and cognitive impairment in maintenance hemodialysis patients
by: Wang Xiao-qi, et al.
Published: (2025-04-01)

Study the Effect of Some Adipokines and Interleukins in Hypo and Hyperthyroidism Patients
by: Firas Faris RIJA, et al.
Published: (2023-09-01)

Visfatin promotes multiple myeloma cell proliferation and inhibits apoptosis by inducing IL-6 production via NF-κB pathways
by: Wenting Tie, et al.
Published: (2025-05-01)

Evaluation of Visceral Adipokines: Omentin, Vaspin, and Visfatin in Patients with Gestational Diabetes Mellitus
by: Mehmet Yilmaz, et al.
Published: (2024-11-01)

The effect of visfatin on the transcriptomic profile of porcine anterior pituitary cells during periimplantation period
by: Kamil Dobrzyn, et al.
Published: (2025-05-01)

Serum visfatin in patients with type two diabetic retinopathy
by: I. N. Salman, et al.
Published: (2024-11-01)

The levels of visfatin and toll-like receptors in arterial hypertension and type 2 diabetes mellitus
by: N. Pokrovska, et al.
Published: (2024-04-01)

Effects of Physical Activity, VO2max, and Visfatin on Relationship Between BMI and Chronic Inflammation
by: Su L, et al.
Published: (2024-11-01)

Effect of non-surgical periodontal therapy on salivary and gingival crevicular fluid concentration of visfatin in periodontal health and disease
by: Hira Ismail, et al.
Published: (2024-07-01)

Role of retinol binding protein 4, visfatin, omentin-1 and vaspin in gout patients with various obesity phenotypes
by: N. N. Pavlova, et al.
Published: (2024-06-01)

CHARACTERISTICS OF LOCAL INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEPENDENCE ON SEVERITY STAGE
by: L. Yu. Dolinina, et al.
Published: (2014-07-01)

Impact of holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk
by: Annalisa Givonetti, et al.
Published: (2024-11-01)

Unraveling the Microenvironment and the Pathogenic Axis of HIF‐1α–Visfatin–Fibrosis in Autoimmune Pancreatitis Using a Single‐Cell Atlas
by: Deyu Zhang, et al.
Published: (2025-03-01)

Relationship of visfatin with obesity and osteoporosis in patients with inflammatory bowel disease: a narrative review
by: Alicja Ewa Ratajczak-Pawłowska, et al.
Published: (2025-03-01)

4-methylumbilliferon (4-MU) as a Potential Treatment Against Cerebral ischemia and Reperfusion Injury in Rats; An Experimental Study
by: Hamzeh Mirshekari Jahangiri, et al.
Published: (2024-09-01)

Prognostic value of type 2 diabetes mellitus and visfatin level in patients after coronary artery bypass grafting
by: Alla A. Garganeeva, et al.
Published: (2023-06-01)

Activation of Automatic Tube Compensation Mode Attenuates Auto‐PEEP in Chronic Obstructive Pulmonary Disease Patients
by: Omid Moradi Moghaddam, et al.
Published: (2024-10-01)

Chronic obstructive pulmonary disease related to wood smoke and impact of the combined exposure to tobacco
by: C.A. Torres-Duque, et al.
Published: (2024-03-01)

Targeting iNAMPT and NAD Biosynthesis to Break the Obesity-Associated Liver Cancer Link
by: Kelly Thornton, et al.
Published: (2025-06-01)

DIAGNOSTIC CAPABILITIES OF DIGITAL FLUOROGRAPHY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Gorbunov, et al.
Published: (2015-02-01)

The Emerging Biomarkers in Chronic Obstructive Pulmonary Disease: A Narrative Review
by: Kaitlin M. Phillips, et al.
Published: (2025-05-01)

Quinine Use and the Risk of Exacerbations of Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Registry Study
by: Vilstrup F, et al.
Published: (2025-05-01)

Association between serum pyridoxal 5′-phosphate levels and chronic obstructive pulmonary disease: findings based on NHANES 2005–2010
by: Yanbin Liu, et al.
Published: (2025-01-01)

Surfactant Protein-D, Fibrinogen, and Interleukin-6 Correlation with Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease
by: Anum Wahid, et al.
Published: (2025-07-01)

Surfactant Protein-D, Fibrinogen, and Interleukin-6 Correlation with Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease
by: Anum Wahid, et al.
Published: (2025-07-01)

Metabolic Aging as an Increased Risk for Chronic Obstructive Pulmonary Disease
by: Claire J. Guo, et al.
Published: (2024-11-01)

Paradigm Shift in the Treatment of Chronic Obstructive Pulmonary Disease Improves Patient Outcomes
by: Huang YJ, et al.
Published: (2025-06-01)

Asthma-chronic obstructive pulmonary disease misdiagnosis: cause for concern or false alarm?
by: M S Barthwal, et al.
Published: (2025-06-01)

Nighttime Cough Characteristics in Chronic Obstructive Pulmonary Disease Patients
by: Albertus C. den Brinker, et al.
Published: (2025-01-01)